NERV logo

Minerva Neurosciences (NERV) Return On Equity

Annual ROE

105.44%
-54.91%-34.24%

December 31, 2023


Summary


Performance

NERV ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNERVprofitabilitymetrics:

Quarterly ROE

10.10%
-93.76%-90.28%

September 30, 2024


Summary


Performance

NERV Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNERVprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

NERV ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-34.2%-92.8%
3 y3 years+2083.0%-92.8%
5 y5 years+289.7%-92.8%

NERV ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-34.2%+116.8%-99.2%+101.4%
5 y5-year-34.2%+116.8%-99.2%+101.4%
alltimeall time-34.2%+101.3%-99.2%+101.4%

Minerva Neurosciences ROE History

DateAnnualQuarterly
Sep 2024
-
10.10%(-90.3%)
Jun 2024
-
103.86%(-19.8%)
Mar 2024
-
129.52%(-5.4%)
Dec 2023
105.44%(-34.2%)
136.96%(-2.1%)
Sep 2023
-
139.94%(-4.1%)
Jun 2023
-
145.99%(-13.8%)
Mar 2023
-
169.28%(-42.8%)
Dec 2022
160.35%(-125.6%)
296.01%(-75.6%)
Sep 2022
-
1213.61%(-266.8%)
Jun 2022
-
-727.58%(+155.6%)
Mar 2022
-
-284.62%(+67.7%)
Dec 2021
-625.73%(<-9900.0%)
-169.75%(+91.7%)
Sep 2021
-
-88.55%(+22.2%)
Jun 2021
-
-72.48%(-829.9%)
Mar 2021
-
9.93%(+138.1%)
Dec 2020
4.83%(-101.9%)
4.17%(-108.1%)
Sep 2020
-
-51.19%(-23.3%)
Jun 2020
-
-66.72%(-58.8%)
Mar 2020
-
-161.96%(+27.9%)
Dec 2019
-259.84%
-126.64%(+65.8%)
Sep 2019
-
-76.38%(+20.0%)
Jun 2019
-
-63.66%(+12.8%)
DateAnnualQuarterly
Mar 2019
-
-56.44%(+19.1%)
Dec 2018
-55.58%(+132.1%)
-47.37%(+49.6%)
Sep 2018
-
-31.67%(+8.5%)
Jun 2018
-
-29.20%(+5.5%)
Mar 2018
-
-27.68%(+2.3%)
Dec 2017
-23.95%(-18.2%)
-27.05%(-27.5%)
Sep 2017
-
-37.31%(+3.3%)
Jun 2017
-
-36.13%(+19.6%)
Mar 2017
-
-30.21%(-1.1%)
Dec 2016
-29.29%(-40.2%)
-30.56%(-9.7%)
Sep 2016
-
-33.83%(-6.3%)
Jun 2016
-
-36.12%(-21.1%)
Mar 2016
-
-45.76%(+10.3%)
Dec 2015
-48.95%(-55.7%)
-41.47%(+2.3%)
Sep 2015
-
-40.54%(-46.2%)
Jun 2015
-
-75.37%(-33.5%)
Mar 2015
-
-113.38%(-14.6%)
Dec 2014
-110.49%(+583.7%)
-132.69%(-9.8%)
Sep 2014
-
-147.16%(+64.4%)
Jun 2014
-
-89.53%(+309.7%)
Mar 2014
-
-21.85%(+35.2%)
Dec 2013
-16.16%(-99.8%)
-16.16%
Dec 2012
-8326.32%
-

FAQ

  • What is Minerva Neurosciences annual return on equity?
  • What is the all time high annual ROE for Minerva Neurosciences?
  • What is Minerva Neurosciences annual ROE year-on-year change?
  • What is Minerva Neurosciences quarterly return on equity?
  • What is the all time high quarterly ROE for Minerva Neurosciences?
  • What is Minerva Neurosciences quarterly ROE year-on-year change?

What is Minerva Neurosciences annual return on equity?

The current annual ROE of NERV is 105.44%

What is the all time high annual ROE for Minerva Neurosciences?

Minerva Neurosciences all-time high annual return on equity is 160.35%

What is Minerva Neurosciences annual ROE year-on-year change?

Over the past year, NERV annual return on equity has changed by -54.91% (-34.24%)

What is Minerva Neurosciences quarterly return on equity?

The current quarterly ROE of NERV is 10.10%

What is the all time high quarterly ROE for Minerva Neurosciences?

Minerva Neurosciences all-time high quarterly return on equity is 1213.61%

What is Minerva Neurosciences quarterly ROE year-on-year change?

Over the past year, NERV quarterly return on equity has changed by -129.84% (-92.78%)